Tietz Fundamentals of Clinical Chemistry
and Molecular Diagnostics, 8th Edition
by Nader Rifai, All Chapters 1-49
,TietzqFundamentalsqofqClinicalqChemistryqandqMolecularqDiagnosticsq8thq EditionqTestqBank
Tableqofqcontents:
I.qPrinciplesqOfqLaboratoryqMedicine
Chapterq1.qClinicalqChemistry,qMolecularqDiagnostics,qandqLaboratoryqMedicine
Chapterq2.qSelectionqandqAnalyticalqEvaluationqofqMethodsq—qWithqStatisticalqTechniques
Chapterq3.qClinicalqEvaluationqofqMethods
Chapterq4.qEvidence-BasedqLaboratoryqMedicine
Chapterq5.qEstablishmentqandqUseqofqReferenceqValues
Chapterq6.qSpecimenqCollection,qProcessing,qandqOtherqPreanalyticalqVariables
Chapterq7.qQualityqManagement
II.qAnalyticalqTechniquesqAndqInstrumentation
Chapterq8.qPrinciplesqofqBasicqTechniquesqandqLaboratoryqSafety
Chapterq9.qOpticalqTechniques
Chapterq10.qElectrochemistryqandqChemicalqSensors
Chapterq11.qElectrophoresis
Chapterq12.qChromatography
Chapterq13.qMassqSpectrometry
Chapterq14.qEnzymeqandqRateqAnalyses
Chapterq15.qImmunochemicalqTechniques
Chapterq16qAutomation
Chapterq17.qPoint-of-CareqInstrumentation
III.q Analytes
Chapterq18.qAminoqAcids,qPeptides,qandqProteins
Chapterq19.qSerumqEnzymes
Chapterq20.qTumorqMarkersqandqCancerqGenes
Chapterq21.qKidneyqFunctionqTestsq—qCreatinine,qGFR,qUrea,qandqUricqAcid
Chapterq22.qCarbohydrates
Chapterq23.qLipids,qLipoproteins,qApolipoproteins,qandqOtherqCardiacqRiskqFactors
Chapterq24.qElectrolytesqandqBloodqGases
Chapterq25.qHormones
Chapterq26.q CatecholaminesqandqSerotonin
Chapterq27.q Vitamins,qTraceqElements,qNutritionalqAssessment
Chapterq28.qHemoglobin,qIron,qandqBilirubin
Chapterq29.qPorphyrinsqandqPorphyrias
Chapterq30.qTherapeuticqDrugsqandqTheirqManagement
Chapterq31.qClinicalqToxicology
Chapterq32.q ToxicqMetals
IV.q Pathophysiology
Chapterq33.qDiabetes
,Chapterq34.q CardiovascularqDisease
Chapterq35.qKidneyqDisease
Chapterq36.q PhysiologyqandqDisordersqofqWater,qElectrolyte,qandqAcid-BaseqMetabolism
Chapterq37.qqLiverqDisease
Chapterq38.q GastrointestinalqandqPancreaticqDiseases
Chapterq39.qqDisordersqofqBoneqandqMineralqMetabolism
Chapterq40.qqDisordersqofqtheqPituitaryqGland
Chapterq41.q DisordersqofqtheqAdrenalqCortex
Chapterq42.q ThyroidqDisorders
Chapterq43.q Reproduction-RelatedqDisorders
Chapterq44.qqPregnancyqandqPrenatalqTesting
Chapterq45.q NewbornqScreeningqandqInbornqErrorsqofqMetabolism
Chapterq46.qPharmacogenetics
V.q MolecularqDiagnostics
Chapterq47.qPrinciplesqofqMolecularqBiology
Chapterq48.qNucleicqAcidqTechniquesqandqApplications
Chapterq49.qGenomesqandqNucleicqAcidqAlterations
, Chapterq01:qClinicalqChemistry,qMolecularqDiagnostics,qandqLaboratoryqMedicineqTe
stqBank
MULTIPLEqCHOICE
1. Anqindividualqworkingqinqaqclinicalqchemistryqlaboratoryqisqmarriedqtoqaqsalesqrepresentativeq
whoqworksqforqaqcompanyqthatqsellsqchemistryqlaboratoryqsupplies.qWhenqtheqlaboratoryqman
agerqrequestsqaqlistqofqneededqsupplies,qcostqofqsupplies,qandqvendors,qthisqindividualqonlyqreco
mmendsqtheqspouse’sqcompanyqasqtheqvendor.qThisqisqconsideredqtoqbeqa(n):
a. accountingqissue.
b. possibleqconflictqofqinterest.
c. maintenanceqofqconfidentialityqissue.
d. problemqwithqresourceqallocation.
ANS:q B
Concernqhasqbeenqraisedqoverqtheqinterrelationshipsqbetweenqpractitionersqinqtheqmedicalqfieldq
andqcommercialqsuppliersqofqdrugs,qdevices,qequipment,qetc.,qtoqtheqmedicalqprofession.
Similarly,qrelationshipsqhaveqbeenqscrutinizedqbetweenqclinicalqlaboratoriansqandqmanufacturer
sqandqprovidersqofqdiagnosticqequipmentqandqsupplies.qTheseqconcernsqledqtheqNationalqInstitut
esqofqHealthq(NIH)qinq1995qtoqrequireqofficialqinstitutionalqreviewqofqfinancialqdisclosureqbyqres
earchersqandqmanagementqofqsituationsqinqwhichqdisclosureqindicatesqpotentialqconflictsqofqinter
est.
DIF: 1 REF:qqqPageq4-5 OBJ:q 6q|q7
2. Aqpatientqvisitsqherqphysicianqstatingqthatqherqprescribedqpainkillerqisqnotqworkingqtoqreduceq
theqpainqfollowingqherqrecentqsurgery.qAqfriendqofqtheqpatientqclaimsqthatqtheqsameqpainkillerq
“workedqwonders”qtoqreduceqherqpainqafterqtheqsameqsurgery.qTheqphysicianqstatesqthatqtheq
differenceqinqtheqeffectqofqtheqdrugqmightqbeqcausedqby
,qwhichqisqstudiedqinqpharmacogenetics.
a. epidemiology
b. anqinheritedqdisease
c. aqconflictqofqinterest
d. aqgeneticqvariationqinqdrug-metabolizingqenzymes
ANS:q D
Pharmacogeneticsqisqtheqstudyqofqtheqgeneticqvariationqofqdrugqmetabolismqbetweenq
individuals.
DIF: 1 REF:qqqPageq3 OBJ:q 1
3. Johnqworksqinqaqmolecularqdiagnosticsqlaboratoryqandqreceivesqaqbloodqsampleqthatqhasqtheq
nameqofqaqcloseqfriendqprintedqonqtheqbar-
codedqlabel.qTheqgeneticqtestqthatqisqorderedqonqtheqfriend’sqsampleqwouldqprovideqdiagnosti
cqinformationqaboutqaqdisorderqthatqhasqaqpoorqprognosis,qandqtheqtestqisqusuallyqperformedq
byqJohn.qHeqasksqaqfellowqemployeeqtoqanalyzeqtheqsampleqforqhimqandqnotqdivulgeqtheqresul
ts.qThisqethicalqissueqconcerns:
a. confidentialityqofqpatientqgeneticqandqmedicalqinformation.
b. aqconflictqofqinterest.
c. resourceqallocation.
d. diagnosticqaccuracy.